Cardiovascular Risk Management in Diabetic Patients Using Ibuprofen
Aspirin Therapy for Primary Prevention
Diabetic adults aged ≥ 50 years who have additional cardiovascular risk factors (e.g., hypertension, dyslipidemia, smoking, family history of CVD, or albuminuria) should receive low‑dose aspirin (75–162 mg daily) for primary cardiovascular prevention, as recommended by the American Diabetes Association. 1, 2
Aspirin Therapy for Secondary Prevention
Diabetic patients with established atherosclerotic cardiovascular disease should continue low‑dose aspirin for secondary prevention, according to American Diabetes Association guidance. 1, 2
NSAID–Aspirin Interaction Considerations
In diabetic patients, the presence of cardiovascular risk factors necessitates careful evaluation when prescribing NSAIDs such as ibuprofen, because ibuprofen may attenuate the antiplatelet effect of concurrent low‑dose aspirin, potentially diminishing cardiovascular protection. 3, 4, 1, 2
Aspirin Therapy and Ibuprofen Use in Adults with Diabetes
Aspirin Recommendations for Cardiovascular Prevention
- The American Diabetes Association (ADA) recommends low‑dose aspirin (75–162 mg daily) for primary cardiovascular prevention in adults with diabetes who are ≥ 50 years old and have additional cardiovascular risk factors. 5
- For patients with established atherosclerotic cardiovascular disease, the ADA strongly recommends low‑dose aspirin for secondary prevention. 5
Renal Function Considerations When Using Ibuprofen
- In diabetic patients with an estimated glomerular filtration rate (eGFR) > 30 mL/min/1.73 m², ibuprofen may be used cautiously for short‑term pain relief, provided dosing does not exceed the OTC maximum of 1,200 mg per day. 6